CEO of vaccine maker sold $10 million in stock before company ruined Johnson & Johnson doses
CEO of vaccine maker sold $10 million in stock before company ruined Johnson & Johnson doses By Jon Swaine The Washington Post,Updated April 26, 2021, 2 hours ago Email to a Friend The Emergent BioSolutions plant in Baltimore, Maryland.Tasos Katopodis/Getty Images via Bloomberg The stock price of government contractor Emergent BioSolutions has fallen sharply since the disclosure at the end of March that production problems at the firmâs plant in Baltimore had ruined 15 million doses of Johnson & Johnsonâs coronavirus vaccine. Since then, AstraZeneca moved production of its own vacci...
Source: bostonglobe.com